These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Advances in meningioma genetics: novel therapeutic opportunities. Preusser M; Brastianos PK; Mawrin C Nat Rev Neurol; 2018 Feb; 14(2):106-115. PubMed ID: 29302064 [TBL] [Abstract][Full Text] [Related]
25. [The DNA methylation profiling in the study and treatment of patients with meningiomas of the craniovertebral junction]. Shimansky VN; Ryzhova MV; Sultanov RA; Tanyashin SV; Galstyan SA; Telysheva EN; Karnaukhov VV Arkh Patol; 2022; 84(6):47-51. PubMed ID: 36469717 [TBL] [Abstract][Full Text] [Related]
27. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Choudhury A; Magill ST; Eaton CD; Prager BC; Chen WC; Cady MA; Seo K; Lucas CG; Casey-Clyde TJ; Vasudevan HN; Liu SJ; Villanueva-Meyer JE; Lam TC; Pu JK; Li LF; Leung GK; Swaney DL; Zhang MY; Chan JW; Qiu Z; Martin MV; Susko MS; Braunstein SE; Bush NAO; Schulte JD; Butowski N; Sneed PK; Berger MS; Krogan NJ; Perry A; Phillips JJ; Solomon DA; Costello JF; McDermott MW; Rich JN; Raleigh DR Nat Genet; 2022 May; 54(5):649-659. PubMed ID: 35534562 [TBL] [Abstract][Full Text] [Related]
28. Atypical meningioma: Histopathological, genetic, and epigenetic features to predict recurrence risk. Marastoni E; Barresi V Histol Histopathol; 2024 Mar; 39(3):293-302. PubMed ID: 37921468 [TBL] [Abstract][Full Text] [Related]
29. Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report. Zhu JJ; Maruyama T; Jacoby LB; Herman JG; Gusella JF; Black PM; Wu JK Neurosurgery; 1999 Aug; 45(2):409-16. PubMed ID: 10449091 [TBL] [Abstract][Full Text] [Related]
30. Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas. Ferreyra Vega S; Wenger A; Kling T; Olsson Bontell T; Jakola AS; Carén H Mod Pathol; 2022 Nov; 35(11):1551-1561. PubMed ID: 35701666 [TBL] [Abstract][Full Text] [Related]
31. DNA methylation in the malignant transformation of meningiomas. Gao F; Shi L; Russin J; Zeng L; Chang X; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Mack WJ; Wang K PLoS One; 2013; 8(1):e54114. PubMed ID: 23349797 [TBL] [Abstract][Full Text] [Related]
32. Histopathologic and Molecular Evaluation of Meningioma. Davidson C Neurosurg Clin N Am; 2023 Jul; 34(3):311-318. PubMed ID: 37210122 [TBL] [Abstract][Full Text] [Related]
33. Correlation between cytogenetic and clinical findings in 215 human meningiomas. Steudel WI; Feld R; Henn W; Zang KD Acta Neurochir Suppl; 1996; 65():73-6. PubMed ID: 8738501 [TBL] [Abstract][Full Text] [Related]
34. Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Patel AJ; Wan YW; Al-Ouran R; Revelli JP; Cardenas MF; Oneissi M; Xi L; Jalali A; Magnotti JF; Muzny DM; Doddapaneni H; Sebastian S; Heck KA; Goodman JC; Gopinath SP; Liu Z; Rao G; Plon SE; Yoshor D; Wheeler DA; Zoghbi HY; Klisch TJ Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21715-21726. PubMed ID: 31591222 [TBL] [Abstract][Full Text] [Related]
36. A Practical Overview on the Molecular Biology of Meningioma. Delgado-López PD; Cubo-Delgado E; González-Bernal JJ; Martín-Alonso J Curr Neurol Neurosci Rep; 2020 Nov; 20(12):62. PubMed ID: 33136206 [TBL] [Abstract][Full Text] [Related]
37. Molecular alterations in meningioma: prognostic and therapeutic perspectives. Birzu C; Peyre M; Sahm F Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025 [TBL] [Abstract][Full Text] [Related]
38. Advances in Central Nervous System Tumor Classification. Malta TM; Snyder J; Noushmehr H; Castro AV Adv Exp Med Biol; 2023; 1416():121-135. PubMed ID: 37432624 [TBL] [Abstract][Full Text] [Related]
39. [Meningiomas: new prognostic factors]. Sanz Esponera J An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599 [TBL] [Abstract][Full Text] [Related]